Futura Medical plc (FRA:GYX)
Germany flag Germany · Delayed Price · Currency is EUR
0.0080
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:12 AM CET

Futura Medical Statistics

Total Valuation

Futura Medical has a market cap or net worth of EUR 3.91 million. The enterprise value is -297,953.

Market Cap3.91M
Enterprise Value -297,953

Important Dates

The next estimated earnings date is Friday, December 12, 2025.

Earnings Date Dec 12, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 306.12M
Shares Outstanding n/a
Shares Change (YoY) +0.70%
Shares Change (QoQ) -0.09%
Owned by Insiders (%) 9.73%
Owned by Institutions (%) 68.58%
Float 245.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.42
PB Ratio 1.10
P/TBV Ratio 1.10
P/FCF Ratio n/a
P/OCF Ratio 7.24
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.04
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 0.58

Financial Position

The company has a current ratio of 2.23

Current Ratio 2.23
Quick Ratio 2.11
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -115.97% and return on invested capital (ROIC) is -72.54%.

Return on Equity (ROE) -115.97%
Return on Assets (ROA) -52.66%
Return on Invested Capital (ROIC) -72.54%
Return on Capital Employed (ROCE) -185.87%
Revenue Per Employee 660,510
Profits Per Employee -524,519
Employee Count14
Asset Turnover 1.06
Inventory Turnover 166.31

Taxes

In the past 12 months, Futura Medical has paid 38,305 in taxes.

Income Tax 38,305
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -97.93% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -97.93%
50-Day Moving Average 0.02
200-Day Moving Average 0.08
Relative Strength Index (RSI) 42.09
Average Volume (20 Days) 9,721

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Futura Medical had revenue of EUR 9.25 million and -7.34 million in losses. Loss per share was -0.02.

Revenue9.25M
Gross Profit 5.96M
Operating Income -7.35M
Pretax Income -7.30M
Net Income -7.34M
EBITDA -7.20M
EBIT -7.35M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 4.30 million in cash and n/a in debt, giving a net cash position of 4.30 million.

Cash & Cash Equivalents 4.30M
Total Debt n/a
Net Cash 4.30M
Net Cash Per Share n/a
Equity (Book Value) 3.55M
Book Value Per Share 0.01
Working Capital 3.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 540,416 and capital expenditures -1.05 million, giving a free cash flow of -513,876.

Operating Cash Flow 540,416
Capital Expenditures -1.05M
Free Cash Flow -513,876
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 64.49%, with operating and profit margins of -79.48% and -79.41%.

Gross Margin 64.49%
Operating Margin -79.48%
Pretax Margin -79.00%
Profit Margin -79.41%
EBITDA Margin -77.91%
EBIT Margin -79.48%
FCF Margin n/a

Dividends & Yields

Futura Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.70%
Shareholder Yield -0.70%
Earnings Yield -187.62%
FCF Yield -13.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Futura Medical has an Altman Z-Score of -1.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.31
Piotroski F-Score 2